Pages without language links
Jump to navigation
Jump to search
The following pages do not link to other language versions.
Showing below up to 50 results in range #110,151 to #110,200.
- The Living Guidelines: Recommendations for UA/NSTEMI in Drug and Substance Abusers Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Recommendations for UA/NSTEMI in Prinzmetal’s Angina Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Recommendations for UA/NSTEMI in patients with Cardiovascular Syndrome X Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Recommendations for choosing diagnostic tests during follow up in patients with Chronic Stable Angina Polling Results for CLASS I Guidelines
- The Living Guidelines: Recommendations for choosing diagnostic tests during follow up in patients with Chronic Stable Angina Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors Polling Results for CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors View the Current CLASS IIa Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: ACE Inhibitors View the Current CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Aldosterone Blockade Polling Results for CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Aldosterone Blockade Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Aldosterone Blockade View the Current CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers Polling Results for CLASS IIb Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers Polling Results for CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers Suggest Revisions to the CLASS IIb Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers View the Current CLASS IIb Guidelines
- The Living Guidelines: Renin-Angiotensin-Aldosterone System Blockers: Angiotensin Receptor Blockers View the Current CLASS I Guidelines
- The Living Guidelines: STEMI
- The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Polling Results for CLASS III Guidelines
- The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Polling Results for CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Polling Results for CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Polling Results for CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Polling Results for CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Polling Results for CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Therapy Polling Results for CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Therapy Polling Results for CLASS I Guidelines
- The Living Guidelines: STEMI Antiplatelet Therapy View the Current CLASS IIa Guidelines
- The Living Guidelines: STEMI Antiplatelet Therapy View the Current CLASS I Guidelines
- The Living Guidelines: STEMI Facilitated PCI Polling Results for CLASS III Guidelines
- The Living Guidelines: STEMI Facilitated PCI Polling Results for CLASS IIb Guidelines
- The Living Guidelines: STEMI Facilitated PCI Polling Results for CLASS I Guidelines
- The Living Guidelines: STEMI Facilitated PCI Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: STEMI Facilitated PCI Suggest Revisions to the CLASS IIb Guidelines